Article Information
- Received January 19, 2000
- Revision received March 14, 2000
- Accepted March 24, 2000
- First published June 15, 2000.
- Version of record published June 15, 2000.
Author Information
- Scott Naisbitt1,
- Juli Valtschanoff2,
- Daniel W. Allison3,
- Carlo Sala1,
- Eunjoon Kim4,
- Ann Marie Craig3,
- Richard J. Weinberg2, and
- Morgan Sheng1
- 1Howard Hughes Medical Institute and Department of Neurobiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114,
- 2Department of Cell Biology and Anatomy, University of North Carolina, Chapel Hill, North Carolina 27599,
- 3Department of Cell and Structural Biology, University of Illinois, Urbana-Champaign, Illinois 61801, and
- 4Department of Pharmacology, Pusan National University, Kumjeong-ku, Pusan 609–735, South Korea
Author contributions
Disclosures
- Received January 19, 2000.
- Revision received March 14, 2000.
- Accepted March 24, 2000.
This work was supported by National Institutes of Health Grants NS35050 (M.S.), NS29879 (R.J.W.), and NS33184 (A.M.C.). M.S. is an Assistant Investigator of the Howard Hughes Medical Institute. C.S. is a Harvard-Armenise Foundation Fellow (Department of Biological and Technical Research, Hospital San Raffaelle, Scientific Institute, San Raffaele, Italy). We are grateful to Richard E. Cheney for myosin-V antibodies and for valuable discussions and scientific input. We thank Stephen M. King for DLC antibody R4058.
Correspondence should be addressed to Morgan Sheng, Howard Hughes Medical Institute/Massachusetts General Hospital, Wellman 423, 50 Blossom Street, Boston, MA 02114. E-mail:sheng{at}helix.mgh.harvard.edu.
Dr. Craig's present address: Department of Anatomy and Neurobiology, Washington University, St. Louis, MO 63110.
Online Impact